Brett Doliner
Houston, TXNPI 1134688260
Payments from drug & device makers
$11,110in general payments, 2019–2025
Across 163 payments — averaging $68.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Boston Scientific$2K
- Shockwave Medical, Inc$404
- Abbott$398
- Pfizer$339
- Amgen$217
- plus $602 from 9 others
What the payments were for
- Grants$2,50023%
- Travel & lodging$3,15328%
- Food & beverage$5,15946%
- Education$2983%
General payments by program year
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 72 | $7,520 |
| Boston Scientific | 18 | $1,628 |
| Shockwave Medical, Inc | 7 | $404 |
| Abbott | 14 | $398 |
| Pfizer | 25 | $339 |
| Amgen | 6 | $217 |
| Bridgebio Pharma, Inc. | 4 | $139 |
| Cardiva Medical, Inc. | 5 | $130 |
| Edwards Lifesciences | 4 | $86 |
| Inari Medical, Inc. | 1 | $85 |
| AstraZeneca | 2 | $47 |
| Sanofi-aventis U.S. LLC | 2 | $46 |
| Lexicon Pharmaceuticals, Inc. | 1 | $27 |
| Bayer | 1 | $27 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 12 | $221 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.